Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury
出版年份 2015 全文链接
标题
Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 172, Issue 4, Pages 957-974
出版商
Wiley
发表日期
2014-10-10
DOI
10.1111/bph.12979
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Emerging Role of MicroRNAs in Cardiovascular Diseases
- (2014) Salvatore De Rosa et al. CIRCULATION JOURNAL
- An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity
- (2014) Laura Cove-Smith et al. TOXICOLOGICAL SCIENCES
- The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Overview
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mechanism-Based Engineering Against Anthracycline Cardiotoxicity
- (2013) Thomas Force et al. CIRCULATION
- An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity With Reduced Proneoplastic Potential
- (2013) Steven M. Jay et al. CIRCULATION
- Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies
- (2013) Bonnie Ky et al. CIRCULATION RESEARCH
- State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: A literature review
- (2013) Rossana Berardi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?
- (2013) Nikolaos Dagres et al. EUROPEAN HEART JOURNAL
- Toxic cardiomyopathy leading to fatal acute cardiac failure related to vandetanib: a case report with histopathological analysis
- (2013) Rafael Selbach Scheffel et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors
- (2013) Alberto Farolfi et al. HEART
- Nilotinib treatment-associated accelerated atherosclerosis: when is the risk justified?
- (2013) A Tefferi LEUKEMIA
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- Angiogenesis Inhibitor Bevacizumab Increases the Risk of Ischemic Heart Disease Associated with Chemotherapy: A Meta-Analysis
- (2013) Xing-Lin Chen et al. PLoS One
- Design and formulation of functional pluripotent stem cell-derived cardiac microtissues
- (2013) N. Thavandiran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coronary Microvascular Pericytes Are the Cellular Target of Sunitinib Malate-Induced Cardiotoxicity
- (2013) V. Chintalgattu et al. Science Translational Medicine
- Phenotypic Profiling of Structural Cardiotoxins In Vitro Reveals Dependency on Multiple Mechanisms of Toxicity
- (2013) Amy Pointon et al. TOXICOLOGICAL SCIENCES
- Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection
- (2012) Martin Štěrba et al. ANTIOXIDANTS & REDOX SIGNALING
- CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy
- (2012) A. Kathleen McClendon et al. CELL CYCLE
- Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
- (2012) David Montani et al. CIRCULATION
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
- (2012) Heloisa Sawaya et al. Circulation-Cardiovascular Imaging
- A tyrosine kinase inhibitor-induced myocardial degeneration in rats through off-target phosphodiesterase inhibition
- (2012) Wenyue Hu et al. JOURNAL OF APPLIED TOXICOLOGY
- Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytes
- (2012) Manuel Chiusa et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials
- (2012) Edith A. Perez et al. MAYO CLINIC PROCEEDINGS
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Validation of an in vitro contractility assay using canine ventricular myocytes
- (2012) A.R. Harmer et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
- (2011) HG Laverty et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Novel Preclinical Strategy for Identifying Cardiotoxic Kinase Inhibitors and Mechanisms of Cardiotoxicity
- (2011) Hui Cheng et al. CIRCULATION RESEARCH
- Sorafenib-associated multivessel coronary artery vasospasm
- (2011) T. Naib et al. HERZ
- Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab
- (2011) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
- (2011) Thomas Force et al. NATURE REVIEWS DRUG DISCOVERY
- Reversible Cardiomyopathy Associated with Sunitinib and Sorafenib
- (2011) Imran Uraizee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel and Integrated Approach for the Identification and Characterization of Drug-induced Cardiac Toxicity in the Dog
- (2011) Alessandro Casartelli et al. TOXICOLOGIC PATHOLOGY
- Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
- (2011) Mark J. Anderton et al. TOXICOLOGIC PATHOLOGY
- An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk
- (2010) CE Pollard et al. BRITISH JOURNAL OF PHARMACOLOGY
- Coronary artery disease mortality in patients treated for hodgkin's disease
- (2010) Jean-François Boivin et al. CANCER
- Cell Communications in the Heart
- (2010) Daniela Tirziu et al. CIRCULATION
- Targeted Deletion of the Extracellular Signal-Regulated Protein Kinase 5 Attenuates Hypertrophic Response and Promotes Pressure Overload–Induced Apoptosis in the Heart
- (2010) Tomomi E. Kimura et al. CIRCULATION RESEARCH
- Insights into cardiovascular side-effects of modern anticancer therapeutics
- (2010) Stefan Stortecky et al. CURRENT OPINION IN ONCOLOGY
- Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
- (2010) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Left Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies
- (2010) Geoffrey J. Yoon et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anthracycline-Induced Cardiomyopathy
- (2010) Daniela Cardinale et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
- (2010) Michael S. Ewer et al. Nature Reviews Cardiology
- Cardiovascular Effects in Rats following Exposure to a Receptor Tyrosine Kinase Inhibitor
- (2010) Shirley A. Aguirre et al. TOXICOLOGIC PATHOLOGY
- Cardiotoxicity Associated with Targeting Kinase Pathways in Cancer
- (2010) Howard R. Mellor et al. TOXICOLOGICAL SCIENCES
- Primary Endothelial Damage Is the Mechanism of Cardiotoxicity of Tubulin-Binding Drugs
- (2010) Igor Mikaelian et al. TOXICOLOGICAL SCIENCES
- Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic- Pharmacodynamic Evaluation of Sunitinib
- (2009) C. L. Bello et al. CLINICAL CANCER RESEARCH
- Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes
- (2009) Malin KB Jonsson et al. Expert Opinion on Drug Discovery
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- PDK1 coordinates survival pathways and -adrenergic response in the heart
- (2009) K. Ito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A framework to assess the translation of safety pharmacology data to humans
- (2009) Jean-Pierre Valentin et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Biochemical Markers for Prediction of Chemotherapy-Induced Cardiotoxicity
- (2008) Alberto Dolci et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
- (2008) M. L. Telli et al. ANNALS OF ONCOLOGY
- Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress
- (2008) G. Y. Oudit et al. CARDIOVASCULAR RESEARCH
- Both EGFR kinase and Src-related tyrosine kinases regulate human ether-à-go-go-related gene potassium channels
- (2008) De-Yong Zhang et al. CELLULAR SIGNALLING
- Deletion of Ptpn11 (Shp2) in Cardiomyocytes Causes Dilated Cardiomyopathy via Effects on the Extracellular Signal–Regulated Kinase/Mitogen-Activated Protein Kinase and RhoA Signaling Pathways
- (2008) Maria I. Kontaridis et al. CIRCULATION
- Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate
- (2008) M. Brave et al. CLINICAL CANCER RESEARCH
- Signaling via the Tgf-β type I receptor Alk5 in heart development
- (2008) Somyoth Sridurongrit et al. DEVELOPMENTAL BIOLOGY
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Deletion of Shp2 Tyrosine Phosphatase in Muscle Leads to Dilated Cardiomyopathy, Insulin Resistance, and Premature Death
- (2008) F. Princen et al. MOLECULAR AND CELLULAR BIOLOGY
- Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload
- (2008) J. A. Muraski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started